EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The ubiquitin–proteasome system: A potential target for the MASLD

Yue Liu, Meijia Qian, Yonghao Li, Xin Dong, Yulian Wu, Tao Yuan, Jian Ma, Bo Yang, Hong Zhu, Qiaojun He

Acta Pharmaceutica Sinica B · 2025-03 · 15 (3) · 1268-1280

DOI: 10.1016/j.apsb.2025.01.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-03. Verfasst von Yue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Deubiquitinase (DUB)E3 ubiquitin ligaseMASLDNeddylationSUMOylationTherapeutic targetsUbiquitin proteasome system (UPS)Ubiquitination

Autor:innen und Institutionen

  • Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Hangzhou Zhongmei Huadong Pharmaceut Co., Ltd., Hangzhou 310011, China.
  • Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • School of Medicine, Hangzhou City University, Hangzhou 310015, China.
  • Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou 310058, China.

Förderung

  • Zhejiang Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Qian, M., Li, Y., Dong, X., Wu, Y., Yuan, T., Ma, J., Yang, B., Zhu, H., & He, Q. (2025). The ubiquitin–proteasome system: A potential target for the MASLD. Acta Pharmaceutica Sinica B, 15(3), 1268-1280. https://doi.org/10.1016/j.apsb.2025.01.010

Vancouver

Liu Y, Qian M, Li Y, Dong X, Wu Y, Yuan T, et al. The ubiquitin–proteasome system: A potential target for the MASLD. Acta Pharmaceutica Sinica B. 2025;15(3):1268-1280. doi:10.1016/j.apsb.2025.01.010

BibTeX
@article{Liu2025,
  author = {Liu, Yue and Qian, Meijia and Li, Yonghao and Dong, Xin and Wu, Yulian and Yuan, Tao and Ma, Jian and Yang, Bo and Zhu, Hong and He, Qiaojun},
  title = {The ubiquitin–proteasome system: A potential target for the MASLD},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {1268--1280},
  doi = {10.1016/j.apsb.2025.01.010}
}
Kostenlos starten →